Spark Therapeutics (Germany) Profile

Spark Therapeutics, Inc. focuses on the development of gene therapy products for patients suffering from debilitating genetic diseases. Spark Therapeutics, Inc. was founded in 2013 and is headquartered in Philadelphia, Pennsylvania. Spark Therapeutics operates under Biotechnology classification in Germany and traded on Frankfurt Stock Exchange. It employs 315 people. more
NameSpark Therapeutics
CEO, Co-Founder, DirectorJeffrey MarrazzoView All
Macroaxis Advice
InstrumentGermany Stock View All
Business Address3737 Market Street
ExchangeFrankfurt Stock Exchange
Phone215 220 9300
CurrencyEUR - Euro

Spark Therapeutics Directors

Spark Therapeutics Corporate Directors

Robert Perez Director
Lars Ekman Independent Director
Lorris Betz Director
Check also Trending Equities. Please also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.